{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:08:21Z","timestamp":1794622101500,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI22\/01193"],"award-info":[{"award-number":["FIS PI22\/01193"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI22\/01193"],"award-info":[{"award-number":["FIS PI22\/01193"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI22\/01193"],"award-info":[{"award-number":["FIS PI22\/01193"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI22\/01193"],"award-info":[{"award-number":["FIS PI22\/01193"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI22\/01193"],"award-info":[{"award-number":["FIS PI22\/01193"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI22\/01193"],"award-info":[{"award-number":["FIS PI22\/01193"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI22\/01193"],"award-info":[{"award-number":["FIS PI22\/01193"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["\u201cA way of making Europe\u201d"],"award-info":[{"award-number":["\u201cA way of making Europe\u201d"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["\u201cA way of making Europe\u201d"],"award-info":[{"award-number":["\u201cA way of making Europe\u201d"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["\u201cA way of making Europe\u201d"],"award-info":[{"award-number":["\u201cA way of making Europe\u201d"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["\u201cA way of making Europe\u201d"],"award-info":[{"award-number":["\u201cA way of making Europe\u201d"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["\u201cA way of making Europe\u201d"],"award-info":[{"award-number":["\u201cA way of making Europe\u201d"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["\u201cA way of making Europe\u201d"],"award-info":[{"award-number":["\u201cA way of making Europe\u201d"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["\u201cA way of making Europe\u201d"],"award-info":[{"award-number":["\u201cA way of making Europe\u201d"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grupo de Investigaci\u00f3n en Servicios Sanitarios de Arag\u00f3n","award":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"],"award-info":[{"award-number":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"]}]},{"name":"Grupo de Investigaci\u00f3n en Servicios Sanitarios de Arag\u00f3n","award":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"],"award-info":[{"award-number":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"]}]},{"name":"Grupo de Investigaci\u00f3n en Servicios Sanitarios de Arag\u00f3n","award":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"],"award-info":[{"award-number":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"]}]},{"name":"Grupo de Investigaci\u00f3n en Servicios Sanitarios de Arag\u00f3n","award":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"],"award-info":[{"award-number":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"]}]},{"name":"Grupo de Investigaci\u00f3n en Servicios Sanitarios de Arag\u00f3n","award":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"],"award-info":[{"award-number":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"]}]},{"name":"Grupo de Investigaci\u00f3n en Servicios Sanitarios de Arag\u00f3n","award":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"],"award-info":[{"award-number":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"]}]},{"name":"Grupo de Investigaci\u00f3n en Servicios Sanitarios de Arag\u00f3n","award":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"],"award-info":[{"award-number":["\"Convocatoria de subvenciones destinadas a fomentar la actividad investigadora de los grupos de investigaci\u00f3n reconocidos por la Administraci\u00f3n de la Comunidad de Arag\u00f3n\" (Arag\u00f3n Government)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>European guidelines recommend the prescription of certain drugs after acute myocardial infarction (AMI). The existence of gender differences in pharmacological treatment after an AMI has been described. This study aims to describe and analyse, using real-world data (RWD), whether there are gender differences in the prescribing patterns and initiation of treatment in secondary prevention after a first AMI, and which are the factors that explain these differences.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A population-based observational study of RWD was conducted in the CARhES (CArdiovascular Risk factors for hEalth Services research) cohort. The study included subjects who had experienced a first episode of AMI between 2017 and 2022, had survived the event, and had a minimum follow-up of 180\u00a0days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>3,975 subjects were followed 180\u00a0days after a first AMI. Women (27.8% of the study population) were older and had more comorbidities. Of the main guideline-recommended drugs, antiplatelets, lipid modifying agents and beta-blockers, were prescribed less often in women. Comedications such as rivaroxaban and calcium channel blockers were more likely to be prescribed in women. The proportion of subjects initiating treatment was similar in both genders.<\/jats:p>\n            <jats:p>Overall, age and morbidity burden were the main contributors to differences in the prescribing patterns. Living in an urban area seemed to be a protective or mitigating factor. There were controversial results regarding socioeconomic level. <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In our study population, women are older, have greater comorbidities and lower socioeconomic status. Despite this, gender inequalities in the prescribing patterns after a first AMI remains, as women appear to experience less therapeutic effort. It is crucial to analyse them from an intersectional perspective, considering the influence of multiple axes of inequality on health, in order to develop gender-sensitive strategies with a multidisciplinary approach.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-025-21396-1","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T08:34:17Z","timestamp":1737102857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gender inequalities in prescribing and initiation patterns of guideline-recommended drugs after acute myocardial infarction"],"prefix":"10.1186","volume":"25","author":[{"given":"Irene","family":"L\u00f3pez-Ferreruela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Malo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Ob\u00f3n-Azuara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Rabanaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Gamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Castel-Feced","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Aguilar-Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"21396_CR1","unstructured":"Mendis S, Puska P, Norrving B, World Health Organization, World Heart Federation. et al. Global atlas on cardiovascular disease prevention and control\/ edited by: Shanthi Mendis ... [ et al.] . World Health Organization;\u00a02011. https:\/\/iris.who.int\/handle\/10665\/44701."},{"key":"21396_CR2","unstructured":"European Heart Network, European Society of Cardiology. Fighting cardiovascular disease - a blueprint for EU Action. Brussels; 2020. Available from: https:\/\/ehnheart.org\/wp-content\/uploads\/2023\/08\/CVD-Plan-digital-edition.pdf."},{"key":"21396_CR3","unstructured":"European Society of Cardiology (ESC). Cardiovascular disease statistics. 2019. Available from: https:\/\/iris.unibocconi.it\/retrieve\/handle\/11565\/4023471\/115818\/Torbica%20EHJ%202019.pdf. [cited 2024 Sept 05]."},{"key":"21396_CR4","unstructured":"World Health Organization. World Health Organization: newsroom, cardiovascular disease (CVDs). 2021. Available from: https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds). [cited 2023 May 20]."},{"key":"21396_CR5","unstructured":"Eurostat. Brussels: European statistics explained; 2024. Deaths from cardiovascular disease statistics; [data extracted in July 2024] Available at: https:\/\/www.ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Cardiovascular_diseases_statistics. Cited 18 December 2024."},{"issue":"1","key":"21396_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.hlc.2020.06.026","volume":"30","author":"K Hyun","year":"2021","unstructured":"Hyun K, Negrone A, Redfern J, Atkins E, Chow C, Kilian J, et al. Gender difference in secondary prevention of cardiovascular disease and outcomes following the survival of acute coronary syndrome. Hear Lung Circ. 2021;30(1):121\u20137.","journal-title":"Hear Lung Circ"},{"issue":"19","key":"21396_CR7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","volume":"36","author":"T Jernberg","year":"2015","unstructured":"Jernberg T, Hasvold P, Henriksson M, et al. Cardiovascular risk in postmyocardial infarction patients: nationwide real-world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36(19):1163\u201370. https:\/\/doi.org\/10.1093\/eurheartj\/ehu505.","journal-title":"Eur Heart J"},{"key":"21396_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12872-019-1238-5","volume":"19","author":"M Sakalaki","year":"2019","unstructured":"Sakalaki M, Barywani S, Rosengren A, et al. Determinants of suboptimal long-term secondary prevention of acute myocardial infarction: the structural interview method and physical examinations. BMC Cardiovasc Disord. 2019;19:243. https:\/\/doi.org\/10.1186\/s12872-019-1238-5.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"21396_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.gheart.2015.04.003","volume":"10","author":"P Perel","year":"2015","unstructured":"Perel P, Avezum A, Huffman M, Pais P, Rodgers A, Vedanthan R, et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease the world heart federation roadmap for secondary prevention of cardiovascular disease. Glob Heart. 2015;10(2):99\u2013110.","journal-title":"Glob Heart"},{"key":"21396_CR10","doi-asserted-by":"publisher","first-page":"5767864","DOI":"10.1155\/2018\/5767864","volume":"2018","author":"SP Karunathilake","year":"2018","unstructured":"Karunathilake SP, Ganegoda GU. Secondary prevention of cardiovascular diseases and application of technology for early diagnosis. BioMed Res Int. 2018;2018:5767864.","journal-title":"BioMed Res Int"},{"key":"21396_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12872-016-0400-6","volume":"16","author":"C Ergatoudes","year":"2016","unstructured":"Ergatoudes C, Thunstr\u00f6m E, Rosengren A, et al. Long-term secondary prevention of acute myocardial infarction (SEPAT) \u2013 guidelines adherence and outcome. BMC Cardiovasc Disord. 2016;16:226. https:\/\/doi.org\/10.1186\/s12872-016-0400-6.","journal-title":"BMC Cardiovasc Disord"},{"issue":"38","key":"21396_CR12","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826.","journal-title":"Eur Heart J"},{"issue":"12","key":"21396_CR13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.recesp.2017.10.049","volume":"70","author":"F Alfonso","year":"2017","unstructured":"Alfonso F, Sionis A, Bueno H, Ib\u00e1\u00f1ez B, Sabat\u00e9 M, Cequier \u00c1, et al. Comentarios a la gu\u00eda ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevaci\u00f3n del segmento ST. Rev Espa\u00f1ola Cardiol. 2017;70(12):1039\u201345.","journal-title":"Rev Espa\u00f1ola Cardiol"},{"issue":"3","key":"21396_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"FJ Neumann","year":"2020","unstructured":"Neumann FJ, Sechtem U, Banning AP, Bonaros N, Bueno H, Bugiardini R, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407\u201377.","journal-title":"Eur Heart J"},{"issue":"6","key":"21396_CR15","doi-asserted-by":"publisher","first-page":"544.e1","DOI":"10.1016\/j.recesp.2020.12.024","volume":"74","author":"J-P Collet","year":"2021","unstructured":"Collet J-P, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, et al. Gu\u00eda ESC 2020 sobre el diagn\u00f3stico y tratamiento del s\u00edndrome coronario agudo sin elevaci\u00f3n del segmento ST. Rev Espa\u00f1ola Cardiol. 2021;74(6):544.e1-544.e73.","journal-title":"Rev Espa\u00f1ola Cardiol"},{"issue":"1","key":"21396_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12939-024-02230-3","volume":"23","author":"I L\u00f3pez Ferreruela","year":"2024","unstructured":"L\u00f3pez Ferreruela I, Ob\u00f3n Azuara B, Malo Fumanal S, Rabanaque Hern\u00e1ndez MJ, Aguilar-Palacio I. Gender inequalities in secondary prevention of cardiovascular disease: a scoping review. Int J Equity Health. 2024;23(1):146. https:\/\/doi.org\/10.1186\/s12939-024-02230-3.","journal-title":"Int J Equity Health"},{"key":"21396_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13054-022-04299-0","volume":"27","author":"K Arslani","year":"2023","unstructured":"Arslani K, Tontsch J, Todorov A, et al. Temporal trends in mortality and provision of intensive care in younger women and men with acute myocardial infarction or stroke. Crit Care. 2023;27:14. https:\/\/doi.org\/10.1186\/s13054-022-04299-0.","journal-title":"Crit Care"},{"issue":"3","key":"21396_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jacc.2017.05.051","volume":"70","author":"LJ Shaw","year":"2017","unstructured":"Shaw LJ, Pepine CJ, Xie J, Mehta PK, Morris AA, Dickert NW, et al. Quality and equitable health care gaps for women: attributions to sex differences in cardiovascular medicine. J Am Coll Cardiol. 2017;70(3):373\u201388.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"21396_CR19","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/eurheartj\/ehz898","volume":"41","author":"A Haider","year":"2020","unstructured":"Haider A, Bengs S, Luu J, Osto E, Siller-Matula JM, Muka T, et al. Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J. 2020;41(13):1328\u201336. https:\/\/doi.org\/10.1093\/eurheartj\/ehz898.","journal-title":"Eur Heart J"},{"issue":"6","key":"21396_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/ph16060869","volume":"16","author":"M Alwhaibi","year":"2023","unstructured":"Alwhaibi M, Balkhi B. Gender differences in potentially inappropriate medication use among older adults. Pharmaceuticals. 2023;16(6):869. https:\/\/doi.org\/10.3390\/ph16060869.","journal-title":"Pharmaceuticals"},{"key":"21396_CR21","unstructured":"US Food and Drug Administration, et al. Real-world evidence. 2022. https:\/\/www.fda.gov\/science-research\/science-andresearch-specialtopics\/real-world-evidence. Accessed 7 Mar 2024."},{"key":"21396_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12874-022-01768-6","volume":"22","author":"F Liu","year":"2022","unstructured":"Liu F, Panagiotakos D. Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol. 2022;22:287. https:\/\/doi.org\/10.1186\/s12874-022-01768-6.","journal-title":"BMC Med Res Methodol"},{"issue":"23","key":"21396_CR23","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","volume":"375","author":"RE Sherman","year":"2016","unstructured":"Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence - what is it and what can it tell us? N Engl J Med. 2016;375(23):2293\u20137. https:\/\/doi.org\/10.1056\/NEJMsb1609216.","journal-title":"N Engl J Med"},{"key":"21396_CR24","unstructured":"Gliklich RE, Dreyer NA, eds. Registries for evaluating patient outcomes: a user\u2019s guide. Agency for Healthcare Research and Quality; 2007. https:\/\/effectivehealthcare.ahrq.gov\/sites\/default\/files\/pdf\/registries-guide_research.pdf. Accessed 19 Dec 2024."},{"issue":"2","key":"21396_CR25","doi-asserted-by":"publisher","first-page":"dyae015","DOI":"10.1093\/ije\/dyae015","volume":"53","author":"I Aguilar-Palacio","year":"2024","unstructured":"Aguilar-Palacio I, Rabanaque M, Castel S, Maldonado L, Gonz\u00e1lez-Garc\u00eda J, Comp\u00e9s L, et al. Cohort Profile: the CArdiovascular Risk factors for hEalth Services research (CARhES) cohort study. Int J Epidemiol. 2024;53(2):dyae015.","journal-title":"Int J Epidemiol"},{"key":"21396_CR26","unstructured":"Ministerio de Sanidad consumo y bienestar Social. Informe del proyecto de Estratificaci\u00f3n de la Poblaci\u00f3n por Grupos de Morbilidad Ajustados (GMA) en Sist Nac Salud. 2018. p. 33\u20139."},{"key":"21396_CR27","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs, 2024. Oslo, Norway 2024. https:\/\/atcddd.fhi.no\/atc_ddd_index_and_guidelines\/atc_ddd_index\/."},{"issue":"5","key":"21396_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691\u2013705. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04167.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"21396_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2307\/2525981","volume":"14","author":"RL Oaxaca","year":"1973","unstructured":"Oaxaca RL. Male-female wage differentials in urban labour markets. Int Econ Rev. 1973;14(3):693\u2013709. https:\/\/doi.org\/10.2307\/2525981.","journal-title":"Int Econ Rev"},{"key":"21396_CR30","unstructured":"R Core Team. R: A Language and environment for statistical computing. (Version 4.1) [Computer software]. 2022. Retrieved from https:\/\/cran.r-project.org. (R packages retrieved from CRAN snapshot 2023\u201304\u201307)."},{"key":"21396_CR31","unstructured":"The jamovi project. jamovi. (Version 2.4) [Computer Software]. 2023. Retrieved from https:\/\/www.jamovi.org."},{"issue":"3","key":"21396_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.rccl.2020.10.009","volume":"56","author":"JM Ruiz-Nodar","year":"2021","unstructured":"Ruiz-Nodar JM, Ferreiro JL, Ribera A, Marsal JR, Garc\u00eda Acu\u00f1a JM, Agra Bermejo R, et al. Sex differences in the management of patients with acute coronary syndrome: a population-based ecological cross-sectional study in Spain. REC CardioClinics. 2021;56(3):168\u201378.","journal-title":"REC CardioClinics"},{"key":"21396_CR33","doi-asserted-by":"publisher","first-page":"131622","DOI":"10.1016\/j.ijcard.2023.131622","volume":"397","author":"E Elia","year":"2024","unstructured":"Elia E, Bruno F, Crimi G, Wa\u0144ha W, Leonardi S, Mauro M, et al. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry. Int J Cardiol. 2024;397:131622.","journal-title":"Int J Cardiol"},{"issue":"1","key":"21396_CR34","doi-asserted-by":"publisher","first-page":"102157","DOI":"10.1016\/j.aprim.2021.102157","volume":"54","author":"G Sotorra-Figuerola","year":"2022","unstructured":"Sotorra-Figuerola G, Ouchi D, Garc\u00eda-Sangen\u00eds A, Giner-Soriano M, Morros R. Pharmacological treatment after acute coronary syndrome: Baseline clinical characteristics and gender differences in a population-based cohort study. Aten Primaria. 2022;54(1):102157.","journal-title":"Aten Primaria"},{"issue":"8","key":"21396_CR35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/clc.22962","volume":"41","author":"E Freisinger","year":"2018","unstructured":"Freisinger E, Sehner S, Malyar NM, Suling A, Reinecke H, Wegscheider K. Nationwide routine-data analysis of sex differences in outcome of acute myocardial infarction. Clin Cardiol. 2018;41(8):1013\u201321.","journal-title":"Clin Cardiol"},{"issue":"4","key":"21396_CR36","first-page":"432","volume":"61","author":"AL Madika","year":"2019","unstructured":"Madika AL, Lemesle G, Lamblin N, Meurice T, Tricot O, Mounier-Vehier C, et al. Gender differences in clinical characteristics, medical management, risk factor control, and long-term outcome of patients with stable coronary artery disease: from the CORONOR registry. Panminerva Med. 2019;61(4):432\u20138.","journal-title":"Panminerva Med"},{"issue":"1","key":"21396_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jjcc.2016.02.022","volume":"69","author":"NA Kassim","year":"2017","unstructured":"Kassim NA, Althouse AD, Qin D, Leef G, Saba S. Gender differences in management and clinical outcomes of atrial fibrillation patients. J Cardiol. 2017;69(1):195\u2013200. https:\/\/doi.org\/10.1016\/j.jjcc.2016.02.022.","journal-title":"J Cardiol"},{"issue":"2","key":"21396_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cardfail.2005.09.005","volume":"12","author":"M Galvao","year":"2006","unstructured":"Galvao M, Kalman J, Demarco T, Fonarow GC, Galvin C, Ghali JK, et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Card Fail. 2006;12(2):100\u20137. https:\/\/doi.org\/10.1016\/j.cardfail.2005.09.005.","journal-title":"J Card Fail"},{"key":"21396_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2021.02.024","volume":"324","author":"Y Rachamin","year":"2021","unstructured":"Rachamin Y, Grischott T, Rosemann T, Meyer MR. Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: a large-scale, cross-sectional study in primary care. Atherosclerosis. 2021;324:141\u20137.","journal-title":"Atherosclerosis"},{"issue":"2","key":"21396_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/eurjpc\/zwaa144","volume":"29","author":"P Vynckier","year":"2022","unstructured":"Vynckier P, Ferrannini G, Ryden L, Jankowski P, De Backer T, Gevaert S, et al. Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry. Eur J Prev Cardiol. 2022;29(2):344\u201351.","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"21396_CR41","doi-asserted-by":"publisher","first-page":"e014742","DOI":"10.1161\/JAHA.119.014742","volume":"9","author":"M Zhao","year":"2020","unstructured":"Zhao M, Woodward M, Vaartjes I, Millett ERC, Klipstein-Grobusch K, Hyun K, et al. Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9(11):e014742.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"21396_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/ehjqcco\/qcab007","volume":"8","author":"M Dagan","year":"2022","unstructured":"Dagan M, Dinh DT, Stehli J, Tan C, Brennan A, Warren J, et al. Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome. Eur Hear J - Qual Care Clin Outcomes. 2022;8(4):420\u20138.","journal-title":"Eur Hear J - Qual Care Clin Outcomes"},{"issue":"12","key":"21396_CR43","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.3390\/jcm10122594","volume":"10","author":"M Setny","year":"2021","unstructured":"Setny M, Jankowski P, Krzykwa A, Kami\u0144ski KA, G\u0105sior Z, Haberka M, et al. Management of dyslipidemia in women and men with coronary heart disease: results from polaspire study. J Clin Med. 2021;10(12):2594.","journal-title":"J Clin Med"},{"issue":"1","key":"21396_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.amjcard.2014.09.041","volume":"115","author":"SS Virani","year":"2015","unstructured":"Virani SS, Woodard LD, Ramsey DJ, Urech TH, Akeroyd JM, Shah T, et al. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015;115(1):21\u20136.","journal-title":"Am J Cardiol"},{"issue":"5","key":"21396_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1089\/jwh.2017.6461","volume":"27","author":"L Abrahamyan","year":"2018","unstructured":"Abrahamyan L, Sahakyan Y, Wijeysundera HC, Krahn M, Rac VE. Gender differences in utilization of specialized heart failure clinics. J Women\u2019s Heal. 2018;27(5):623\u20139.","journal-title":"J Women\u2019s Heal"},{"issue":"6","key":"21396_CR46","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/ijerph17062136","volume":"17","author":"AG Guti\u00e9rrez","year":"2020","unstructured":"Guti\u00e9rrez AG, Poblador-Plou B, Prados-Torres A, Laiglesia FJR, Gimeno-Miguel A. Sex differences in comorbidity, therapy, and health services\u2019 use of heart failure in Spain: Evidence from real-world data. Int J Environ Res Public Health. 2020;17(6):2136.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"21396_CR47","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1056\/NEJMoa2208275","volume":"387","author":"JM Castellano","year":"2022","unstructured":"Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, et al. Polypill strategy in secondary cardiovascular prevention. N Engl J Med. 2022;387(11):967\u201377.","journal-title":"N Engl J Med"},{"issue":"6","key":"21396_CR48","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.recesp.2020.04.031","volume":"74","author":"L Rodr\u00edguez-Padial","year":"2021","unstructured":"Rodr\u00edguez-Padial L, Fern\u00e1ndez-P\u00e9rez C, Bernal JL, Anguita M, Sambola A, Fern\u00e1ndez-Ortiz A, et al. Differences in in-hospital mortality after STEMI versus NSTEMI by sex. Eleven-year trend in the Spanish National Health Service. Rev Esp Cardiol. 2021;74(6):510\u20137.","journal-title":"Rev Esp Cardiol"},{"issue":"5","key":"21396_CR49","doi-asserted-by":"publisher","first-page":"102486","DOI":"10.1016\/j.cpcardiol.2024.102486","volume":"49","author":"F Zilio","year":"2024","unstructured":"Zilio F, Musella F, Ceriello L, Ciliberti G, Pavan D, Manes MT, et al. Sex differences in patients presenting with acute coronary syndrome: a state-of-the-art review. Curr Probl Cardiol. 2024;49(5):102486.","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"21396_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-020-05946-4","volume":"20","author":"F Kirsch","year":"2020","unstructured":"Kirsch F, Becker C, Kurz C, Schwettmann L, Schramm A. Effects of adherence to 550 pharmacological secondary prevention after acute myocardial infarction on health care 551 costs \u2013 an analysis of real-world data. BMC Health Serv Res. 2020;20(1):1\u201317.","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"21396_CR51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/heartjnl-2020-317549","volume":"107","author":"D De Bacquer","year":"2021","unstructured":"De Bacquer D, Van De Luitgaarden IAT, De Smedt D, Vynckier P, Bruthans J, Fras Z, et al. Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile. Heart. 2021;107(10):799\u2013806.","journal-title":"Heart"},{"issue":"1","key":"21396_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-6966-z","volume":"19","author":"C Roth","year":"2019","unstructured":"Roth C, Berger R, Kuhn M. The role of the socio-economic environment on medical outcomes after ST-segment elevation myocardial infarction. BMC Public Health. 2019;19(1):1\u201314. https:\/\/doi.org\/10.1186\/s12889-019-6966-z.","journal-title":"BMC Public Health"},{"issue":"1087","key":"21396_CR53","first-page":"1","volume":"13","author":"V Venditti","year":"2023","unstructured":"Venditti V, Bleve E, Morano S, Filardi T. Gender-related factors in medication adherence for metabolic and cardiovascular health. Metabolites. 2023;13(1087):1\u201326.","journal-title":"Metabolites"},{"issue":"1","key":"21396_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-019-1134-9","volume":"17","author":"A Arrospide","year":"2019","unstructured":"Arrospide A, Mach\u00f3n M, Ramos-Go\u00f1i JM, Ibarrondo O, Mar J. Inequalities in health-related quality of life according to age, gender, educational level, social class, body mass index and chronic diseases using the Spanish value set for Euroquol 5D\u20135L questionnaire. Health Qual Life Outcomes. 2019;17(1):1\u201310. https:\/\/doi.org\/10.1186\/s12955-019-1134-9.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"21396_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-10236-7","volume":"21","author":"J Tetzlaff","year":"2021","unstructured":"Tetzlaff J, Geyer S, Westhoff-Bleck M, Sperlich S, Epping J, Tetzlaff F. Social inequalities in mild and severe myocardial infarction: how large is the gap in health expectancies? BMC Public Health. 2021;21(1):1\u201310. https:\/\/doi.org\/10.1186\/s12889-021-10236-7.","journal-title":"BMC Public Health"},{"key":"21396_CR56","unstructured":"Duch Guillot J. Parlamento Europeo. Brecha salarial de g\u00e9nero en Europa: hechos y cifras. 2023. Available from: https:\/\/www.europarl.europa.eu\/pdfs\/news\/expert\/2020\/3\/story\/20200227STO73519\/20200227STO73519_es.pdf. [cited 2024 Aug 13]."},{"issue":"1","key":"21396_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.hlc.2020.06.025","volume":"30","author":"J Stehli","year":"2021","unstructured":"Stehli J, Duffy SJ, Burgess S, Kuhn L, Gulati M, Chow C, et al. Sex disparities in myocardial infarction: biology or bias? Hear Lung Circ. 2021;30(1):18\u201326. https:\/\/doi.org\/10.1016\/j.hlc.2020.06.025.","journal-title":"Hear Lung Circ"},{"issue":"6","key":"21396_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjopen\/oeae087","volume":"4","author":"S Manzo-Silberman","year":"2024","unstructured":"Manzo-Silberman S, Hawranek M, Banerjee S, Kaluzna-Oleksy M, Alasnag M, Paradies V, et al. Call to action for acute myocardial infarction in women: international multi-disciplinary practical roadmap. Eur Hear J Open. 2024;4(6):1\u20139. https:\/\/doi.org\/10.1093\/ehjopen\/oeae087.","journal-title":"Eur Hear J Open"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21396-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-21396-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21396-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T08:34:29Z","timestamp":1737102869000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-21396-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21396"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-21396-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is based on data from the CARhES cohort. The CARhES cohort protocol was approved by the Ethics Committee for Clinical Research in Aragon (CEICA PI21\/148). As there was no direct contact or interaction with the study participants and given the retrospective and population characteristics of the study, informed consent was waived by the Ethics Committee.All data were treated in a strictly confidential manner following the ethical principles of the Declaration of Helsinki of 1964, and in compliance with the Organic Law 3\/2018 on the Protection of Personal Data and Guarantee of Digital Rights in Spain.Declaration of Helsinki by the World Medical Association: .Spanish Organic Law on Data Protection 3\/2018: .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}